These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 277233)
21. Response of human squamous cell carcinoma xenografts of different sizes to irradiation: relationship of clonogenic cells, cellular radiation sensitivity in vivo, and tumor rescuing units. Baumann M; Dubois W; Suit HD Radiat Res; 1990 Sep; 123(3):325-30. PubMed ID: 2145606 [TBL] [Abstract][Full Text] [Related]
22. The effect of misonidazole in situ on the radiation response of selected tumor subpopoulations. Grdina DJ; Sigdestad CP; Jovonovich JA Cancer Clin Trials; 1980; 3(2):149-54. PubMed ID: 7428138 [TBL] [Abstract][Full Text] [Related]
23. Combinations of radiation and misonidazole in a murine lung tumor model. Siemann DW; Kochanski K Radiat Res; 1981 May; 86(2):387-97. PubMed ID: 7232698 [No Abstract] [Full Text] [Related]
24. Proceedings: An "in vitro" colony assay for human humours: radiation survival in a pancreatic tumour xenograft. Courtenay VD; Mills J Br J Radiol; 1976 Jun; 49(582):558. PubMed ID: 1276633 [No Abstract] [Full Text] [Related]
25. The novel hypoxic cell radiosensitizer, TX-1877 has antitumor activity through suppression of angiogenesis and inhibits liver metastasis on xenograft model of pancreatic cancer. Miyake K; Shimada M; Nishioka M; Sugimoto K; Batmunkh E; Uto Y; Nagasawa H; Hori H Cancer Lett; 2008 Dec; 272(2):325-35. PubMed ID: 18762366 [TBL] [Abstract][Full Text] [Related]
26. In vivo assay of the radiation sensitivity of hypoxic tumour cells; influence of gamma-rays cyclotron neutrons, misonidazole, hyperthermia and mixed modalities. Porschen W; Gartzen J; Geweher K; Mühlensiepen H; Weber HJ; Feinedegen LE Br J Cancer Suppl; 1978 Jun; 3():194-7. PubMed ID: 277225 [TBL] [Abstract][Full Text] [Related]
27. Radiosensitization by misonidazole (Ro-07-0582) of fractionated X-rays in a murine tumour. Sheldon PW; Fowler JF Br J Cancer Suppl; 1978 Jun; 3():242-5. PubMed ID: 277239 [TBL] [Abstract][Full Text] [Related]
28. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2. Pyo H; Choy H; Amorino GP; Kim JS; Cao Q; Hercules SK; DuBois RN Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687 [TBL] [Abstract][Full Text] [Related]
29. Sensitizing and toxicity properties of misonidazole and its derivatives. Whitmore GF; Gulyas S; Varghese AJ Br J Cancer Suppl; 1978 Jun; 3():115-9. PubMed ID: 277210 [No Abstract] [Full Text] [Related]
30. Radiosensitization of human colorectal tumor cells by 4-nitro-5-sulfonatoimidazoles. Fitzpatrick DA; Heindel ND; Egolf RA; Walton H Radiat Res; 1989 Jan; 117(1):47-58. PubMed ID: 2913608 [TBL] [Abstract][Full Text] [Related]
31. In vitro radiation response of cells from four human tumors propagated in immune-suppressed mice. Smith IE; Courtenay VD; Mills J; Peckham MJ Cancer Res; 1978 Feb; 38(2):390-2. PubMed ID: 202386 [TBL] [Abstract][Full Text] [Related]
32. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma. Ohizumi Y; Murayama C; Maezawa H; Mori T Tokai J Exp Clin Med; 1984 Oct; 9(4):331-7. PubMed ID: 6537042 [TBL] [Abstract][Full Text] [Related]
33. Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation. el-Said A; Menke D; Dorie MJ; Brown JM Radiat Oncol Investig; 1999; 7(3):163-9. PubMed ID: 10406058 [TBL] [Abstract][Full Text] [Related]
34. [Toxic and radiosensitizing effect of reduced nitroimidazoles on E. coli B/r cells]. Riabchenko NI; Semin IuA; Petrova KM; Kutmin AI Radiobiologiia; 1983; 23(4):505-9. PubMed ID: 6351162 [TBL] [Abstract][Full Text] [Related]
35. Structure-activity relationships of 1-substituted 2-nitroimidazoles: effect of partition coefficient and side-chain hydroxyl groups on radiosensitization in vitro. Brown DM; Parker E; Brown JM Radiat Res; 1982 Apr; 90(1):98-108. PubMed ID: 7199747 [No Abstract] [Full Text] [Related]
36. SR-2508 plus buthionine sulfoximine or SR-2508 alone: effects on the radiation response and the glutathione content of a human tumor xenograft. Lespinasse F; Biscay P; Malaise EP; Guichard M Radiat Res; 1987 Apr; 110(1):149-54. PubMed ID: 2951766 [TBL] [Abstract][Full Text] [Related]
37. Bromomisonidazole: synthesis and characterization of a new radiosensitizer. Rasey JS; Krohn KA; Freauff S Radiat Res; 1982 Sep; 91(3):542-54. PubMed ID: 7122830 [No Abstract] [Full Text] [Related]
38. Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer. McNally NJ; Denekamp J; Sheldon P; Flockhart IR; Stewart FA Radiat Res; 1978 Mar; 73(3):568-80. PubMed ID: 273269 [No Abstract] [Full Text] [Related]
39. Cytotoxic effects of the hypoxic cell radiosensitizer Ro 7-0582 to tumor cells in vivo. Brown JM Radiat Res; 1977 Dec; 72(3):469-86. PubMed ID: 594322 [No Abstract] [Full Text] [Related]
40. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor. Petersen C; Petersen S; Milas L; Lang FF; Tofilon PJ Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]